Valuation: Solventum Corporation

Market Cap 14.86B 13.27B 12.34B 11.23B 21.2B 1,438B 21.29B 149B 58.22B 733B 55.8B 54.58B 2,353B P/E 2026 *
48x
P/E 2027 * 22.1x
Enterprise Value 19.74B 17.63B 16.4B 14.92B 28.16B 1,910B 28.28B 197B 77.33B 974B 74.12B 72.5B 3,125B EV / Sales 2026 *
2.4x
EV / Sales 2027 * 2.25x
Free-Float
82.35%
Yield 2026 *
-
Yield 2027 * -
1 day+1.02%
1 week-0.64%
Current month-0.98%
1 month-0.41%
3 months+13.81%
6 months+32.68%
Current year+10.16%
1 week 85.25
Extreme 85.25
88.93
1 month 85.25
Extreme 85.25
91.87
Current year 62.38
Extreme 62.38
94.16
1 year 62.38
Extreme 62.38
94.16
3 years 47.16
Extreme 47.16
96.05
5 years 47.16
Extreme 47.16
96.05
10 years 47.16
Extreme 47.16
96.05
Date Insider Type Main position Quantity % Market Cap. Importance
9/1/26 Exercice

Chief Executive Officer

160,990 0.0930%
8/17/26 Free

Controller/Auditor

6,911 0.0040%
5/15/26 Free

Director

3,300 0.0019%
Change 5-day change 1-year change 3-year change Capi.($)
+1.02%-0.64%+23.78% - 14.86B
+1.13%+2.15%-24.87%+2.09% 172B
+0.83%+2.43%-7.30%+16.15% 113B
+0.13%+0.69%-23.94%+1.05% 106B
+2.34%+2.49%-46.47%-11.84% 75.31B
+0.78%+4.79%+1.84%+72.29% 61.8B
+0.12%+3.62%+15.06%+65.87% 52.93B
+0.55%+3.93%-1.51%-31.24% 50.05B
+0.95%-0.08%-15.93%+14.93% 40.81B
+1.45%+1.83% - - 31.81B
Average +0.93%+2.01%-8.81%+16.16% 71.95B
Weighted average by Cap. +0.92%+2.18%-15.44%+12.50%

Financials

2026 *2027 *
Net sales 8.23B 7.35B 6.84B 6.22B 11.74B 796B 11.79B 82.29B 32.24B 406B 30.9B 30.23B 1,303B 8.52B 7.61B 7.08B 6.44B 12.16B 825B 12.21B 85.22B 33.39B 421B 32B 31.3B 1,349B
Net income 319M 285M 265M 241M 456M 30.92B 458M 3.19B 1.25B 15.76B 1.2B 1.17B 50.59B 688M 615M 572M 520M 982M 66.63B 987M 6.88B 2.7B 33.97B 2.59B 2.53B 109B
Net Debt 4.88B 4.36B 4.05B 3.69B 6.96B 472B 6.99B 48.78B 19.11B 241B 18.32B 17.92B 772B 4.27B 3.82B 3.55B 3.23B 6.1B 414B 6.13B 42.75B 16.75B 211B 16.05B 15.7B 677B
Projected Income Statement - Annual - Solventum Corporation
Logo Solventum Corporation
Solventum Corporation specializes in the marketing of tools used in the medical field. Net sales break down by group of products as follows: - medical instruments and accessories (57.9%): for wound care, sterilization, surgery, etc.; - medical information systems (16.3%): primarily software solutions for documentation, billing, coding, data visualization, etc. in hospital settings; - dental and orthodontic instruments and accessories (16.2%): for dental care and restoration; - purification and filtration instruments (6%): used in the medical, bio-pharmaceutical, agri-food and other sectors; - other (3.6%). The United States accounts for 56.1% of net sales.
Employees
20,584
Date Price Change Volume
26-10-09 US$87.29 +1.02% 1,063,934
26-10-08 US$86.41 +0.62% 1,286,548
26-10-07 US$85.88 -1.33% 981,192
26-10-06 US$87.04 -1.12% 914,158
26-10-05 US$88.03 +0.20% 1,044,021
Trader
Investor
Global
Quality
ESG MSCI
BBB
Ratings Surperformance© - Solventum Corporation
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
15
Last Close Price
87.29USD
Average target price
94.31USD
Spread / Average Target
+8.04%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Solventum Corporation
  1. Stock Market
  2. Stocks
  3. SOLV Stock